TransMedics Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TMDX research report →
About the company
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs.
- CEO
- Waleed H. Hassanein
- IPO
- 2019
- Employees
- 728
- HQ
- Andover, MA, US
Price Chart
- Market Cap
- $2.38B
- P/E
- 13.69
- P/S
- 3.74
- P/B
- 4.79
- EV/EBITDA
- 19.91
- Div Yield
- 0.00%
- Gross Margin
- 59.09%
- Op Margin
- 14.85%
- Net Margin
- 27.04%
- ROE
- 41.92%
- ROIC
- 6.94%
- Revenue
- $605.49M · 37.13%
- Net Income
- $190.29M · 436.58%
- EPS
- $5.60 · 423.36%
- Op Income
- $108.58M
- FCF YoY
- 265.04%
- 52W High
- $156.00
- 52W Low
- $60.10
- 50D MA
- $76.94
- 200D MA
- $113.35
- Beta
- 1.88
- Avg Volume
- 1.35M
Get TickerSpark's AI analysis on TMDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 15, 26 | Gunderson Thomas J. | other | 19,285 |
| Jun 15, 26 | Gunderson Thomas J. | sell | 9,624 |
| Jun 15, 26 | Gunderson Thomas J. | other | 19,285 |
| May 20, 26 | Lovell Stephanie | other | 2,922 |
| May 20, 26 | Weill David | other | 2,922 |
| May 20, 26 | RAINES MERILEE | other | 2,922 |
| May 20, 26 | Gunderson Thomas J. | other | 2,922 |
| May 20, 26 | Basile Edward M | other | 2,922 |
| May 20, 26 | TOBIN JAMES R | other | 2,922 |
| May 20, 26 | Kania Edwin | other | 2,922 |
Our TMDX coverage
Recent articles, reports, and earnings notes.
No research on TMDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TMDX report →Similar companies
Peers in the same neighborhood.